Identification of the soluble EphA7-interacting protein Nicalin as a regulator of EphA7 expression

被引:0
|
作者
Xiaolei Wang
Zhaobao Wang
机构
[1] Shandong University,School of Control Science and Engineering
[2] Shandong First Medical University & Shandong Academy of Medical Sciences,State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Shandong Eye Institute
来源
关键词
Nicalin; sEphA7; EphA7-FL; Antagonistic mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
A soluble form of EphA7 (sEphA7) has been found to antagonize the role of full-length EphA7 (EphA7-FL) to stabilize the membrane level of the tight junction protein Claudin6 (CLDN6) during Xenopus pronephros development. However, the mechanism underlying this antagonistic effect remains unclear. In this study, we identified Nicalin, a Nicastrin-like protein, as a novel sEphA7-interacting protein using immunoprecipitation (IP)/mass spectrometry (MS). In HEK293 cells, Nicalin interacted with sEphA7 and they predominantly co-localized in the endoplasmic reticulum (ER). Interestingly, Nicalin diminished the protein level of sEphA7 in the membranous fraction but increased that in the insoluble cytoplasmic fraction with a reduced molecular weight, suggesting that Nicalin restricts the entry of sEphA7 into the ER for further modification. sEphA7 probably acted as a chaperone and enhanced the membrane level of EphA7-FL and the formation of EphA7 complex, however, this effect was reversed by Nicalin. Our work suggested that Nicalin limits sEphA7 secretion, thereby preventing the formation of EphA7 complex. These results demonstrated the potential role of Nicalin in regulating EphA7 expression and revealed a potential mechanism underlying the antagonistic effect between sEphA7 and EphA7-FL.
引用
收藏
页码:213 / 220
页数:7
相关论文
共 50 条
  • [41] EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
    Zhen Zhang
    Hao-Xiang Wu
    Wu-Hao Lin
    Zi-Xian Wang
    Lu-Ping Yang
    Zhao-Lei Zeng
    Hui-Yan Luo
    BMC Medicine, 19
  • [42] EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
    Zhang, Zhen
    Wu, Hao-Xiang
    Lin, Wu-Hao
    Wang, Zi-Xian
    Yang, Lu-Ping
    Zeng, Zhao-Lei
    Luo, Hui-Yan
    BMC MEDICINE, 2021, 19 (01)
  • [43] EphA7 promotes myogenic differentiation via cell-cell contact
    Arnold, Laura L.
    Cecchini, Alessandra
    Stark, Danny A.
    Ihnat, Jacqueline
    Craigg, Rebecca N.
    Carter, Amory
    Zino, Sammy
    Cornelison, D. D. W.
    ELIFE, 2020, 9
  • [44] Distribution of the receptor EphA7 and its ligands in development of the mouse nervous system
    Rogers, JH
    Ciossek, T
    Ullrich, A
    West, E
    Hoare, M
    Muir, EM
    MOLECULAR BRAIN RESEARCH, 1999, 74 (1-2): : 225 - 230
  • [45] Identification of EphA7 BAC clone containing a long-range dorsal midline-specific enhancer
    Kim, Yujin
    Park, Soochul
    BMB REPORTS, 2011, 44 (02) : 113 - 117
  • [46] Identification of the 187 bp EphA7 Genomic DNA as the Dorsal Midline-Specific Enhancer of the Diencephalon and Mesencephalon
    Kim, Yujin
    Park, Eunjeong
    Park, Soochul
    MOLECULES AND CELLS, 2015, 38 (11) : 1007 - 1012
  • [47] Role of the EphA4 and EphA7 genes in mediating the growth and aggressiveness of medulloblastoma tumors in the Smo/Smo medulloblastoma mouse model
    Baig, Nimrah A.
    Rodriguez, Olga
    Pasquale, Elena
    Dritschilo, Anatoly
    Donoghue, Maria
    Timofeeva, Olga
    Albanese, Christopher
    Karam, Sana D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] EphA7 is required for otic epithelial homeostasis by modulating Claudin6 in Xenopus
    Wang, Xiaolei
    Sun, Jian
    Wang, Zhaobao
    Li, Chaocui
    Mao, Bingyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 526 (02) : 375 - 380
  • [49] Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression
    Li, Shibao
    Wu, Zhiyuan
    Ma, Ping
    Xu, Yinhai
    Chen, Yuming
    Wang, Hua
    He, Ping
    Kang, Zhihua
    Yin, Lingyu
    Zhao, Yao
    Zhang, Xinju
    Xu, Xiao
    Ma, Xiaochao
    Guan, Ming
    CELL DEATH & DISEASE, 2017, 8 : e3122 - e3122
  • [50] 小细胞肺癌中EphA7表达及其临床意义
    王佩
    王婧雅
    范雪涵
    张宇嘉
    黄鼎智
    肿瘤, 2019, 39 (07) : 558 - 567